BISvsSPYG
ProShares UltraShort Nasdaq Biotechnology against SPDR Portfolio S&P 500 Growth ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BIS | SPYG | |
|---|---|---|
| Expense ratio | 0.95% | 0.040% |
| Assets | $1850.59T | $56.6B |
| Net flow, 1 month | — | +$1.1B |
| Net flow, 1 year | +$2K | +$4.8B |
| Return, YTD | -38.6% | +15.6% |
| Return, 1 year | -53.1% | +17.6% |
| Avg daily volume | 9K | 2.1M |
| Holdings | 7 | 228 |
| Listed | Apr 8, 2010 | Sep 24, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS